Results 121 to 130 of about 4,942,192 (218)

Role of Tertiary Lymphoid Structures in Autoimmune Diseases and Cancer

MedComm, Volume 7, Issue 9, September 2026.
Schematic overview of tertiary lymphoid structures (TLSs): The development process, detection, and the immune function that depends on the environment in different disease contexts of TLS. TLSs originate from loose lymphoid aggregates that acquire ordered follicular architecture to become primary follicular‐like TLS, before maturing into ...
Ze Yan, Bin Wen, Ying Hu, Xiaocui Wang, Xuemei Duan, Haonan Li, Shumin Dong, Yufeng Fan, Caihong Wang, Shutong Yang, Huifeng Shang, Yukai Jing   +11 more
wiley   +1 more source

Atypical Presentation of Infantile Bullous Pemphigoid with Isolated C3 Deposits

Indian Journal of Paediatric Dermatology
Bullous pemphigoid is an acquired autoimmune bullous disorder with autoantibodies targeting distinctive antigenic components of the skin and mucous membrane.
Sri Vidya Pidaparty, Jahnavi Sambangi, P. Guruprasad   +2 more
doaj   +1 more source

Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity

Dermatology Practical & Conceptual, 2019
Soheil Tavakolpour, Hamidreza Mahmoudi, Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh   +4 more
doaj   +1 more source

Bullous pemphigoid and associated autoimmune thrombocytopenia: two case reports.

, 1993
We describe two patients with bullous pemphigoid in whom autoimmune thrombocytopenia developed. Only one case of bullous pemphigoid associated with autoimmune thrombocytopenia has previously been reported, and in that case, autoimmune hemolytic anemia ...
Vanessa Venning, Taylor, G, Fenella Wojnarowska, Venning, V, Gayle Taylor, Wojnarowska, Fenella   +5 more
core   +1 more source

Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual‐Center Study

The Journal of Dermatology, Volume 53, Issue 9, Page 1353-1357, September 2026.
ABSTRACT Biologic therapies targeting Type 2 inflammation are increasingly used in bullous pemphigoid, yet the relationship between pruritus and distinct disease domains remains incompletely defined. We conducted a retrospective international dual‐center study of 25 patients with bullous pemphigoid treated with dupilumab, omalizumab, or tralokinumab ...
Ruggero Cascio Ingurgio, Angela Alfano, Aalia Syed, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Dedee F. Murrell   +6 more
wiley   +1 more source

The Autoimmune Bullous Diseases

Journal of the Royal College of Physicians of London, 1997
S H, Wakelin, M M, Black
openaire   +2 more sources

Updates on the Management of Autoimmune Bullous Diseases

Indian Dermatology Online Journal
Abstract Background: Autoimmune bullous diseases are associated with high morbidity and mortality. Traditionally, systemic corticosteroids and conventional immunosuppressive agents have been the mainstay of treatment, but their broad immunosuppressive effects and long-term complications have prompted the exploration ...
Rajat Choudhary, Vishal Gupta, Sujay Khandpur   +2 more
openaire   +3 more sources

European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing—Recommendations on Best Practice (Update 2026)

Contact Dermatitis, Volume 95, Issue 3, Page 237-275, September 2026.
ABSTRACT The present guideline updates the initial ESCD patch testing guideline, summarizing all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions
Wolfgang Uter, Olivier Aerts, Tove Agner, Richard Brans, Magnus Bruze, Alicia Cannavó, Marie‐Noёlle Crépy, Ana M. Giménez‐Arnau, Margarida Gonçalo, An Goossens, Swen M. John, Carola Lidén, Suzana Ljubojević Hadžavdić, Vera Mahler, Mihaly Matura, Esen Özkaya, Maria Pesonen, Nadia Raison‐Peyron, Thomas Rustemeyer, Radoslaw Spiewak, Luca Stingeni, Ian R. White, S. Mark Wilkinson, Jeanne Duus Johansen   +23 more
wiley   +1 more source

Scoring Criteria for Autoimmune Bullous Diseases: Utility, Merits, and Demerits

Indian Dermatology Online Journal
Background: Scoring systems play a crucial role in dermatology by providing objective measurements of disease severity, treatment efficacy, and outcome comparisons. In autoimmune blistering diseases (AIBDs), standardized scoring systems are essential for
Henry Tseng, Corey Stone, Dédée F. Murrell   +2 more
doaj   +1 more source

Skin-Related Quality of Life During Autoimmune Bullous Disease Course.

JAMA Dermatol, 2023
Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM.   +10 more
europepmc   +1 more source